SUBSCRIBE
SUBSCRIBE

Ipsen Announces the Launch of Dysport(R) (abobotulinumtoxinA) in the United States for the Treatment of Cervical Dystonia

October 29, 2009 | 
1 min read
PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris: IPN), an innovation-driven global specialty pharmaceutical group, today announced that Dysport® is now available in the United States for the treatment of cervical dystonia in adults.
Europe
MORE ON THIS TOPIC
Creative poster collage of two business partners having deal financial payment giving money banknote isolated on beige color background.
Manufacturing
Samsung Biologics inks $262M manufacturing deal with European pharma company
September 11, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Conceptual origami paper plane pulling business finance growth chart line flying upwards on blue sky background.
Manufacturing
Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision
September 9, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Illustration of businessmen moving a mountain uphill. The men & mountain and background are on separate labeled layers.
Insights
Can Benelux turn scientific strength into larger biotech scale?
September 8, 2026
 · 
4 min read
 · 
Jennifer C. Smith-Parker
Creative design. Desperate employee, office worker standing near question mark symbolizing business struggles, options. Choosing strategy for achieving goal. Concept of business, career development
Business
4 CDMOs to consider when outsourcing manufacturing
September 8, 2026
 · 
5 min read
 · 
Angela Gabriel